NEXGEL (NXGL) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Revenue grew 31.5% year-over-year to $11.4 million, driven by branded consumer products and the full-year impact of the Silly George acquisition.
Gross profit margin improved to 39.5% from 31.6% in the prior year, reflecting higher-margin product mix.
Net loss attributable to stockholders was $3.0 million, an improvement from $3.3 million in the prior year.
The company continues to focus on expanding its consumer product portfolio and contract manufacturing business.
Financial highlights
Revenues: $11.4 million in 2025 vs. $8.7 million in 2024 (+31.5%).
Gross profit: $4.5 million in 2025 vs. $2.7 million in 2024; gross margin 39.5% vs. 31.6%.
Net loss: $3.0 million in 2025 vs. $3.3 million in 2024.
Cash and equivalents: $317 thousand at year-end, with $741 thousand in restricted cash.
Working capital: $1.4 million at year-end, down from $2.6 million prior year.
Outlook and guidance
Management expects continued near-term losses but is focused on expanding sales channels and product offerings.
Strategic objectives include growing contract manufacturing, launching new branded products, and pursuing acquisitions.
Additional capital raises may be necessary to support growth and acquisitions.
Latest events from NEXGEL
- Hydrogel innovation and strategic partnerships fuel rapid growth and expanding product lines.NXGL
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Record Q2 revenue and strong outlook driven by branded products and Silly George growth.NXGL
Q2 20242 Feb 2026 - Q3 revenue up 141% to $2.94M, gross margin 43.6%, but losses and risks persist.NXGL
Q3 202414 Jan 2026 - Strong growth from product innovation, acquisitions, and major partnerships, with profitability in focus.NXGL
IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 202411 Jan 2026 - Record revenue growth and improved margins set stage for positive EBITDA in 2025.NXGL
Q4 202424 Dec 2025 - Shareholders will vote on director elections, incentive plan expansion, and executive pay, all backed by the Board.NXGL
Proxy Filing2 Dec 2025 - Vote to increase authorized common stock to 1B shares for future flexibility is recommended.NXGL
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 121%, margin at 42.4%, and positive EBITDA targeted for 2025.NXGL
Q1 202527 Nov 2025 - Q2 2025 revenue doubled and margins improved, but going concern risks persist.NXGL
Q2 202523 Nov 2025